Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Microscience Microscopy Congress 2025

The Microscience Microscopy Congress (mmc2025), incorporating EMAG 2025, is set to return as one of Europe's most significant events in its field. This congress will [...]

Go to Top